“centers-for-disease-control-and-prevention” Archives

in
Entry Author Date Location
Stratatech Begins Test of Engineered Skin for Diabetic Foot Ulcers 02/14/18 Wisconsin
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback 02/14/18 Boston
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
NeuroPointDX Turns to Crowdfunding to Get Key Study Past Finish Line 01/23/18 Wisconsin
Bio Roundup: Spark’s Road Ahead, Juno Rumors, Merck’s Big Day & More 01/19/18 National
Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More 01/12/18 National
Medicines Co. Sells Infectious Disease Drugs, Focusing on PCSK9 11/29/17 New York
KalVista, Merck Partnership on Blindness Drug Sends Shares Skyward 10/10/17 Boston
FluGen, Startup Developing Universal Flu Vaccine, Raises $5.5M 08/01/17 Wisconsin
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
The Medicines Co., Alnylam Take Plunge, Outline Big Test For Heart Drug 04/26/17 New York
Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies 04/11/17 Boston
With Fresh Pneumonia Data, Paratek To Seek 2018 Antibiotic Approval 04/03/17 Boston
Tesaro’s Ovarian Cancer Drug Gets FDA Nod, No Diagnostic Needed 03/27/17 Boston
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
No Pain, No High: Nektar’s Opioid Drug Hits Trial Goals, Lifts Shares 03/20/17 San Francisco
With FDA’s Blessing, Seres Preps New “Pivotal” Microbiome Drug Trial 03/16/17 Boston
Backed by $37M, Virta Tries Tech Approach to “Reverse” Diabetes 03/08/17 San Francisco
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Senate Confirms Price for HHS, But Stock Deals Still Raise Questions 02/10/17 National
Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease 12/14/16 Boston
Tenaya Spins Out of Gladstone With $50M to Fight Heart Disease 12/07/16 San Francisco
Procrastinator’s Special Ends Today for State of the Biotech Union 12/05/16 San Francisco
Eli Lilly Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 12/02/16 Indiana
Trump Tabs Fiscal, Social Conservatives To Run U.S. Health Agencies 11/29/16 National
Keeping Lead in Migraine Drug Race, Amgen Touts Data, Preps FDA Filing 11/16/16 San Francisco
With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3 11/15/16 New York
Startup Bill, Water Council, CDI, & More: This Week’s WI Watchlist 09/26/16 Wisconsin
In Cholesterol Drug Price Fight, Real Message Is “Wait Til Next Year” 08/18/16 National
Zurex Pharma’s Antimicrobial Attracts $6.2M for Clinical Trial 08/11/16 Wisconsin
Page 2 of 4 « previous page · next page »